Glanbia plc (FRA:GL9)

Market Cap	3.93B +9.2%
Revenue (ttm)	3.35B -20.1%
Net Income	102.54M -62.2%
EPS	0.39 -61.0%
Shares Out	n/a
PE Ratio	38.37
Forward PE	13.57
Dividend	0.41 (2.59%)
Ex-Dividend Date	Aug 21, 2025

Volume	n/a
Average Volume	n/a
Open	15.66
Previous Close	15.82
Day's Range	15.66 - 15.66
52-Week Range	8.90 - 15.82
Beta	n/a
RSI	65.51
Earnings Date	Feb 25, 2026

About Glanbia

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; pro...

• Industry: Pharmaceutical Preparations
• Founded: 1964
• Employees: 5,791
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GL9

Financial Performance

In fiscal year 2024, Glanbia's revenue was $3.84 billion, a decrease of -29.23% compared to the previous year's $5.43 billion. Earnings were $164.70 million, a decrease of -52.18%.

Financial numbers in USD